Heuron
PrivateLast Round
Series D
Dec 1, 2024
Est. Valuation
$178.23M
Total Funding Raised
$32.14M
Company Overview
Heuron is a healthcare technology company that provides AI-based diagnostic aid solutions for central nervous system diseases, including Alzheimer's, Parkinson's, and stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heuron Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Heuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 1, 2024 | ||||
| Series C | May 1, 2021 | ||||
| Series B | Jul 22, 2020 | ||||
| Series A | Jul 4, 2019 |
Key People
Founding team and executive leadership
Heuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series B |
| Korea Investment Partners | Series B |
| LogInvestment | Series C |
| Korea Growth Investment Corporation | Series C |
| HB Investment | Series C, Series B, Series D |
| We Ventures | Series B |
| Korea Investment & Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2025
Attended the 2025 Korean Emergency Medicine Academic Conference in Gwangju.
Heuron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Heuron's valuation, stock price, and market status.